Effects of dry needling and soft tissue release in treatment of migraine patients

Phase 2

• Conditions: Migraine patients.; Other specified cerebrovascular diseases; I67.8

• Registration Number: IRCT20171219037956N1
• Lead Sponsor: niversity of social welfare and rehabilitation sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1.A neurologist selected the study subjects based on IHS criteria for diagnosis of migraine.
2.The patients in this study were between the ages of 25 and 55 years old
The patients with migraine were examined to find any active trigger points in UT, SCM, sub-occipital muscles . The presence of active trigger points was confirmed if 1- There was an area of focal muscle tenderness that was activated by palpation and that, when activated, referred pain replicating the patient’s headache complaint. 2- There was a jump sign that was the characteristic behavioral response to pressure on a trigger point” .
One diagnostic test in particular, the flexion–rotation test, is said to determine C1-2 dysfunction .Patient was supine position. With the subject relaxed and the cervical spine is fully flexed with the occiput resting against the examiners. The head is then rotated to the left and the right. If firm resistance is percieved, pain provoked and range is limited before the expected end range .The normal range is reported at 44-45 degrees, therefore, the test is positive when the range of motion is more than 10 degrees from the normal range.Studies have shown that migraine has a small effect on the range of motion during this test, but this test shows the presence or absence of cervicogenic headache and this test can use for Differential Diagnosis between migraine headache and cervicogenic headache.The positive test indicates a cervicogenic headache

Exclusion Criteria

history of cervical disc herniation, unusual migraine, heart failure, pulmonary failure, kidney failure, liver failure, circulation failure, diabetes mellitus
patients who were using opioid prophylaxis, anti -depressant, anti-anxiety drugs
subjects who were pregnant or breastfeeding and
Those who having trigger point therapy within the past month before the study
The patients, who underwent DN, had no contraindication for needling such as local infection, pregnancy with threatened abortion, taking anticoagulants

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
2-Headache intensity. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.;3-Headache duration. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.;Number of drug consumption. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.;1-Headache frequency. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.

Secondary Outcome Measures

Name	Time	Method
1.Pressure pain threshold. Timepoint: Before, After and 1month follow up. Method of measurement: Algometer.;2-Muscle thickness. Timepoint: Before, After and 1month follow up. Method of measurement: Ultrasonography.;3-Range of motion. Timepoint: Before, After and 1month follow up. Method of measurement: Goniometer.;4-Neck disability index. Timepoint: Before, After and 1month follow up. Method of measurement: Neck disability index questionnaire.;5-Head disability index. Timepoint: Before, After and 1month follow up. Method of measurement: Head disability index questionnaire.;6-Pain intensity. Timepoint: Before, After and 1month follow up. Method of measurement: Visual analog scale.